A new cancer injection is making global headlines after doctors reported powerful results in patients with advanced head and neck cancer that had returned or spread after standard treatments stopped working. The treatment is called amivantamab. In an international trial, 102 patients received the jab once every 3 weeks. Tumors shrank or disappeared in 43 patients, and in 15 patients, doctors reported that the tumors were completely eradicated. What makes this breakthrough so exciting is the way the dr8g works. It blocks EGFR and MET, 2 signals cancer cells can use to grow and resist treatment. At the same time, it helps the immune system recognize and attack the tumor more effectively. This is not a universal cure, and researchers are still studying who benefits most. But for people with treatment resistant cancer and limited options, these results are being called unusually strong and deeply hopeful. The injection may also be easier for patients than long intravenous treatments, because it is given under the skin in a quicker outpatient process. #TheSciencePulse #fblifestyle #cancerresearch #medicalbreakthrough